Respiratory Distress Syndrome Research Report 2021-2027
This report contains market size and forecasts of Respiratory Distress Syndrome in Global, including the following market information:
Global Respiratory Distress Syndrome Market Revenue, 2016-2021, 2022-2027, ($
millions)
Global top five companies in 2020 (%)
The global Respiratory Distress Syndrome market was valued at 404.6 million in
2020 and is projected to reach US$ 496.7 million by 2027, at a CAGR of 5.3%
during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Respiratory Distress Syndrome
companies, and industry experts on this industry, involving the
revenue, demand, product type, recent developments and plans, industry trends,
drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Distress Syndrome Market, By Type, 2016-2021, 2022-2027 ($
millions)
Global Respiratory Distress Syndrome Market Segment Percentages, By Type, 2020
(%)
Poractant Alfa
Beractant
Calfactant
Others
China Respiratory Distress Syndrome Market, By Application,
2016-2021, 2022-2027 ($ millions)
China Respiratory Distress Syndrome Market Segment Percentages, By Application,
2020 (%)
Very Preterm Infants
Moderate to Late Preterm Infants
Others
Global Respiratory Distress Syndrome Market, By Region and
Country, 2016-2021, 2022-2027 ($ Millions)
Global Respiratory Distress Syndrome Market Segment Percentages, By Region and
Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Respiratory Distress Syndrome Market Competitors Revenues in Global, by
Players 2016-2021 (Estimated), ($ millions)
Total Respiratory Distress Syndrome Market Competitors Revenues Share in
Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including
the following:
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Respiratory Distress Syndrome Market
Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Distress Syndrome Market
Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Respiratory Distress Syndrome Overall
Market Size
2.1 Global Respiratory Distress Syndrome Market
Size: 2021 VS 2027
2.2 Global Respiratory Distress Syndrome Market
Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and
Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Distress Syndrome Players in
Global Market
3.2 Top Global Respiratory Distress Syndrome
Companies Ranked by Revenue
3.3 Global Respiratory Distress Syndrome Revenue
by Companies
3.4 Top 3 and Top 5 Respiratory Distress
Syndrome Companies in Global Market, by Revenue in 2020
3.5 Global Companies Respiratory Distress
Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory
Distress Syndrome Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Distress
Syndrome Companies
3.6.2 List of Global Tier 2 and Tier 3
Respiratory Distress Syndrome Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Respiratory Distress
Syndrome Market Size Markets, 2021 & 2027
4.1.2 Poractant Alfa
4.1.3 Beractant
4.1.4 Calfactant
4.1.5 Others
4.2 By Type - Global Respiratory Distress
Syndrome Revenue & Forecasts
4.2.1 By Type - Global Respiratory Distress
Syndrome Revenue, 2016-2021
4.2.2 By Type - Global Respiratory Distress
Syndrome Revenue, 2022-2027
4.2.3 By Type - Global Respiratory Distress
Syndrome Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Respiratory
Distress Syndrome Market Size, 2021 & 2027
5.1.2 Very Preterm Infants
5.1.3 Moderate to Late Preterm Infants
5.1.4 Others
5.2 By Application - Global Respiratory Distress
Syndrome Revenue & Forecasts
5.2.1 By Application - Global Respiratory
Distress Syndrome Revenue, 2016-2021
5.2.2 By Application - Global Respiratory
Distress Syndrome Revenue, 2022-2027
5.2.3 By Application - Global Respiratory
Distress Syndrome Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Respiratory Distress
Syndrome Market Size, 2021 & 2027
6.2 By Region - Global Respiratory Distress
Syndrome Revenue & Forecasts
6.2.1 By Region - Global Respiratory Distress
Syndrome Revenue, 2016-2021
6.2.2 By Region - Global Respiratory Distress
Syndrome Revenue, 2022-2027
6.2.3 By Region - Global Respiratory Distress
Syndrome Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Respiratory
Distress Syndrome Revenue, 2016-2027
6.3.2 US Respiratory Distress Syndrome Market
Size, 2016-2027
6.3.3 Canada Respiratory Distress Syndrome
Market Size, 2016-2027
6.3.4 Mexico Respiratory Distress Syndrome
Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Respiratory Distress
Syndrome Revenue, 2016-2027
6.4.2 Germany Respiratory Distress Syndrome
Market Size, 2016-2027
6.4.3 France Respiratory Distress Syndrome
Market Size, 2016-2027
6.4.4 U.K. Respiratory Distress Syndrome Market
Size, 2016-2027
6.4.5 Italy Respiratory Distress Syndrome Market
Size, 2016-2027
6.4.6 Russia Respiratory Distress Syndrome
Market Size, 2016-2027
6.4.7 Nordic Countries Respiratory Distress Syndrome
Market Size, 2016-2027
6.4.8 Benelux Respiratory Distress Syndrome
Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Respiratory Distress
Syndrome Revenue, 2016-2027
6.5.2 China Respiratory Distress Syndrome Market
Size, 2016-2027
6.5.3 Japan Respiratory Distress Syndrome Market
Size, 2016-2027
6.5.4 South Korea Respiratory Distress Syndrome
Market Size, 2016-2027
6.5.5 Southeast Asia Respiratory Distress
Syndrome Market Size, 2016-2027
6.5.6 India Respiratory Distress Syndrome Market
Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Respiratory
Distress Syndrome Revenue, 2016-2027
6.6.2 Brazil Respiratory Distress Syndrome
Market Size, 2016-2027
6.6.3 Argentina Respiratory Distress Syndrome
Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa
Respiratory Distress Syndrome Revenue, 2016-2027
6.7.2 Turkey Respiratory Distress Syndrome
Market Size, 2016-2027
6.7.3 Israel Respiratory Distress Syndrome
Market Size, 2016-2027
6.7.4 Saudi Arabia Respiratory Distress Syndrome
Market Size, 2016-2027
6.7.5 UAE Respiratory Distress Syndrome Market
Size, 2016-2027
7 Players Profiles
7.1 Chiesi Farmaceutici
7.1.1 Chiesi Farmaceutici Corporate Summary
ALSO READ : http://www.marketwatch.com/story/regional-dark-chocolate-industry-status-and-professional-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2021-2027-2021-07-26
7.1.2 Chiesi Farmaceutici Business Overview
7.1.3 Chiesi Farmaceutici Respiratory Distress
Syndrome Major Product Offerings
7.1.4 Chiesi Farmaceutici Respiratory Distress
Syndrome Revenue in Global (2016-2021)
7.1.5 Chiesi Farmaceutici Key News
7.2 CR-Double Crane
7.2.1 CR-Double Crane Corporate Summary
7.2.2 CR-Double Crane Business Overview
7.2.3 CR-Double Crane Respiratory Distress
Syndrome Major Product Offerings
7.2.4 CR-Double Crane Respiratory Distress
Syndrome Revenue in Global (2016-2021)
7.2.5 CR-Double Crane Key News
7.3 ONY Biotech
7.3.1 ONY Biotech Corporate Summary
7.3.2 ONY Biotech Business Overview
7.3.3 ONY Biotech Respiratory Distress Syndrome
Major Product Offerings
7.3.4 ONY Biotech Respiratory Distress Syndrome
Revenue in Global (2016-2021)
7.3.5 ONY Biotech Key News
7.4 AbbVie
7.4.1 AbbVie Corporate Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Respiratory Distress Syndrome Major
Product Offerings
7.4.4 AbbVie Respiratory Distress Syndrome
Revenue in Global (2016-2021)
7.4.5 AbbVie Key News
7.5 Yuhan Corporation
7.5.1 Yuhan Corporation Corporate Summary
7.5.2 Yuhan Corporation Business Overview
7.5.3 Yuhan Corporation Respiratory Distress
Syndrome Major Product Offerings
7.5.4 Yuhan Corporation Respiratory Distress
Syndrome Revenue in Global (2016-2021)
7.5.5 Yuhan Corporation Key News
7.6 JW Pharmaceuticals
7.6.1 JW Pharmaceuticals Corporate Summary
7.6.2 JW Pharmaceuticals Business Overview
7.6.3 JW Pharmaceuticals Respiratory Distress
Syndrome Major Product Offerings
7.6.4 JW Pharmaceuticals Respiratory Distress
Syndrome Revenue in Global (2016-2021)
7.6.5 JW Pharmaceuticals Key News
7.7 Noargen
7.7.1 Noargen Corporate Summary
7.7.2 Noargen Business Overview
7.7.3 Noargen Respiratory Distress Syndrome
Major Product Offerings
7.4.4 Noargen Respiratory Distress Syndrome
Revenue in Global (2016-2021)
7.7.5 Noargen Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Respiratory Distress Syndrome Market
Opportunities & Trends in Global Market
Table 2. Respiratory Distress Syndrome Market
Drivers in Global Market
Table 3. Respiratory Distress Syndrome Market
Restraints in Global Market
Table 4. Key Players of Respiratory Distress
Syndrome in Global Market
Table 5. Top Respiratory Distress Syndrome
Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Respiratory Distress Syndrome
Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Respiratory Distress Syndrome
Revenue Share by Companies, 2016-2021
Table 8. Global Companies Respiratory Distress
Syndrome Product Type
Table 9. List of Global Tier 1 Respiratory
Distress Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3
Respiratory Distress Syndrome Companies, Revenue (US$, Mn) in 2020 and Market
Share
Table 11. By Type – Global Respiratory Distress
Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Respiratory Distress
Syndrome Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Respiratory Distress
Syndrome Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Respiratory
Distress Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Respiratory Distress
Syndrome Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Respiratory Distress
Syndrome Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Respiratory
Distress Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Respiratory
Distress Syndrome Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Respiratory
Distress Syndrome Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Respiratory
Distress Syndrome Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Respiratory
Distress Syndrome Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Respiratory
Distress Syndrome Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Respiratory
Distress Syndrome Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Respiratory Distress
Syndrome Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Respiratory Distress
Syndrome Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Respiratory
Distress Syndrome Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Respiratory
Distress Syndrome Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Respiratory
Distress Syndrome Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa
Respiratory Distress Syndrome Revenue, (US$, Mn), 2022-2027
Table 30. Chiesi Farmaceutici Corporate Summary
Table 31. Chiesi Farmaceutici Respiratory Distress
Syndrome Product Offerings
Table 32. Chiesi Farmaceutici Respiratory
Distress Syndrome Revenue (US$, Mn), (2016-2021)
Table 33. CR-Double Crane Corporate Summary
Table 34. CR-Double Crane Respiratory Distress
Syndrome Product Offerings
Table 35. CR-Double Crane Respiratory Distress
Syndrome Revenue (US$, Mn), (2016-2021)
Table 36. ONY Biotech Corporate Summary
Table 37. ONY Biotech Respiratory Distress
Syndrome Product Offerings
Table 38. ONY Biotech Respiratory Distress
Syndrome Revenue (US$, Mn), (2016-2021)
Table 39. AbbVie Corporate Summary
Table 40. AbbVie Respiratory Distress Syndrome
Product Offerings
Table 41. AbbVie Respiratory Distress Syndrome
Revenue (US$, Mn), (2016-2021)
Table 42. Yuhan Corporation Corporate Summary
Table 43. Yuhan Corporation Respiratory Distress
Syndrome Product Offerings
Table 44. Yuhan Corporation Respiratory Distress
Syndrome Revenue (US$, Mn), (2016-2021)
Table 45. JW Pharmaceuticals Corporate Summary
Table 46. JW Pharmaceuticals Respiratory
Distress Syndrome Product Offerings
Table 47. JW Pharmaceuticals Respiratory
Distress Syndrome Revenue (US$, Mn), (2016-2021)
Table 48. Noargen Corporate Summary
Table 49. Noargen Respiratory Distress Syndrome
Product Offerings
Table 50. Noargen Respiratory Distress Syndrome Revenue
(US$, Mn), (2016-2021)
List of Figures
Figure 1. Respiratory Distress Syndrome Segment
by Type
Figure 2. Respiratory Distress Syndrome Segment
by Application
Figure 3. Global Respiratory Distress Syndrome
Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Respiratory Distress Syndrome
Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Respiratory Distress Syndrome
Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share
by Respiratory Distress Syndrome Revenue in 2020
Figure 8. By Type - Global Respiratory Distress
Syndrome Revenue Market Share, 2016-2027
Figure 9. By Application - Global Respiratory
Distress Syndrome Revenue Market Share, 2016-2027
Figure 10. By Region - Global Respiratory
Distress Syndrome Revenue Market Share, 2016-2027
Figure 11. By Country - North America
Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 12. US Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Respiratory
Distress Syndrome Revenue Market Share, 2016-2027
Figure 16. Germany Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 17. France Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Respiratory Distress
Syndrome Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Respiratory Distress
Syndrome Revenue Market Share, 2016-2027
Figure 24. China Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Respiratory Distress
Syndrome Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Respiratory Distress
Syndrome Revenue, (US$, Mn), 2016-2027
Figure 28. India Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Respiratory
Distress Syndrome Revenue Market Share, 2016-2027
Figure 30. Brazil Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Respiratory Distress
Syndrome Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa
Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 33. Turkey Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Respiratory Distress
Syndrome Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Respiratory Distress Syndrome
Revenue, (US$, Mn), 2016-2027
Figure 37. Chiesi Farmaceutici Respiratory
Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. CR-Double Crane Respiratory Distress
Syndrome Revenue Year Over Year Growth (US$, Mn) & (2
....continued
CONTACT DETAILS
+44 203 500 2763
+1 62 825 80070
971 0503084105
Comments
Post a Comment